Veterinary Price Opacity Preventing Informed Consumer Decision-Making

Approximately 80% of veterinary practices in the US and UK do not publish procedure prices on their websites, do not provide estimates over the phone, and present itemized costs only after treatment has begun or been completed — meaning pet owners cannot comparison-shop, budget, or give truly informed consent before committing to a treatment plan that may cost hundreds or thousands of dollars. So what? Pet owners routinely experience bill shock when a 'routine' visit for vomiting turns into a $2,000-$4,000 diagnostic workup with blood panels, imaging, and IV fluids, with each line item revealed only on the final invoice. So what? The inability to compare prices means identical procedures vary wildly between practices — TPLO knee surgery ranges from $3,500 at transparent clinics to $8,000+ at opaque specialty hospitals for the same surgical outcome — and owners have no way to discover this variance before committing. So what? Price opacity disproportionately harms lower-income pet owners who would benefit most from knowing which clinic offers affordable care, effectively creating a system where the wealthiest owners pay whatever is charged while lower-income owners forgo treatment or surrender their pets. So what? The UK Competition and Markets Authority (CMA) 2025 investigation found veterinary prices increased 63% between 2016 and 2023 — far exceeding inflation — and specifically identified lack of transparency as enabling above-market pricing, particularly at corporate-owned veterinary chains. So what? Unlike human healthcare, where price transparency regulations (CMS Hospital Price Transparency Rule) now require published prices, no equivalent regulation exists for veterinary medicine in any US jurisdiction, and there is no industry self-regulatory standard for price disclosure. Structural root cause: Veterinary medicine operates outside health care price transparency regulations because animals are legally property, not patients with consumer protection rights; the AVMA's Principles of Veterinary Medical Ethics discourage advertising that could be seen as 'misleading' but do not require price disclosure; and corporate consolidation of veterinary practices (Mars, NVA, VCA control thousands of clinics) creates market power that reduces competitive pressure to publish prices.